Requirement is for a single cell injection microscope system.

Ended Purchase Order Awarded Last action

Contract number
1333ND21PNB640243
Awardee
Awarding agency
Obligated
$570,441

Award facts

Opportunity
Contract value 85% obligated
  • $570,440.95 Current, with exercised options
  • $673,900.95 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Gaithersburg, MD 20899, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P25007 · OU63-25-OPT-059 exercise option period 3 $30,258
Other Administrative Action P24006 · Administrative modification to change the contracting officer's representative. $0
Exercise an Option P24005 · Exercise option period 2 for extended warranty. $30,258
Other Administrative Action P24004 · Modification to change the contracting officer's representative. $0
Exercise an Option P23003 · Exercise option period 1 for extended warranty. $30,258
Supplemental Agreement for work within scope P22002 $0
Other Administrative Action P21001 · Reallocate accounting string for line item 1 of the purchase order. $0
Original award $479,668

About this award

The U.S. National Institute of Standards and Technology (NIST) awarded a firm fixed-price purchase order contract to Cytosurge AG, a Switzerland-based manufacturer, for a single cell injection microscope system. The $673,900.95 contract supports NIST's standards development efforts for regenerative medicine through precision mammalian cell engineering and clonal cell line development. The microscope system must enable automated single cell injection, isolation, and monitoring capabilities with environmental control and integrated microscopy for visualization. This sole-source award was made without a set-aside, as NIST determined Cytosurge's FluidFM BOT BIO instrument to be the only equipment meeting the stated requirements.

Quick answers

Who was awarded contract 1333ND21PNB640243?

1333ND21PNB640243 was awarded to Cytosurge AG by National Institute of Standards and Technology (Department of Commerce) on June 23, 2021.

How much is contract 1333ND21PNB640243 worth?

The government has obligated $570,441 on 1333ND21PNB640243. Its potential value, with all options, is $673,901.

Was contract 1333ND21PNB640243 competed?

The extent of competition for 1333ND21PNB640243 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award